Source：The Insides Company Limited
On：14 December 2023
Organisations：The Insides Company Limited, Rivolution GmbH
The Insides Company, a medical technology company focused on the development and commercialisation of novel chyme reinfusion therapy (CRT) devices for the treatment of intestinal failure, today announced RiVolution GmbH as the exclusive partner for Germany and Austria following a signing of the distribution agreement.
Innovation is a corporate philosophy at RiVolution. New ideas that become innovative product solutions delivering real benefit to the patients’ well-being is at the core of the company. Therefore, The Insides Company matched perfectly with our company stated Thomas Geir CEO of RiVolution. “We look forward to bringing this innovative solution to enable the benefits of chyme reinfusion therapy to be realised in patients with these challenging conditions in Germany and Austria”.
Garth Sutherland, CEO of The Insides Company, commented “we are excited by the opportunity to work with the excellent team at RiVolution. From our first meetings Thomas and the team could see the benefits of chyme reinfusion and with their strong network in colorectal surgery, they are an ideal partner for representing our products in Germany and Austria. With a lot of interest already received from clinicians, we are confident of a successful partnership with them.”
About Type II Intestinal Failure and Chyme Reinfusion Therapy
Type II intestinal failure is the inability of the gut to absorb necessary water, macronutrients, micronutrients, and electrolytes to sufficiently sustain life without intravenous supplementation or replacement. This can be due to malabsorption (small bowel mucosal disease), surgical resection (short bowel syndrome), fistulae, dysmotility, or mechanical obstruction. Under the standard care pathway, patients recovering from colorectal surgery often have an enterostomy created to divert intestinal contents (chyme) away from the surgical site as it heals. The enterostomy is typically left open for 6-12 months, and during this time the chyme that is collected is disposed of, which can result in intestinal failure and other complications. The Insides System is a purpose-built medical device for performing chyme reinfusion therapy. Chyme reinfusion is a practice in the management of patients with high-output enterocutaneous fistulas, and high-output enterostomies.
About RiVOLUTiON®
RiVOLUTiON® GmbH stands for innovative product solutions and high service expertise in Medical technology. Our mission is to distribute developments in a new way to look for future-oriented solutions and new or proven technologies with innovative features and great benefits to patient treatments. The company is headquartered in Rosenheim (Upper Bavaria) and serves as the starting point for the entire delivery process, from the warehouse to smooth on-site logistics.
About The Insides Company
The Insides Company has commercialised 30 years of clinical experience in gut nutrition into breakthrough medical devices. The Insides Company’s mission is to provide universal access to chyme reinfusion therapy through revolutionary products and education to establish a new standard of care.
Contacts
RiVolution GmbH
Thomas Geir, CEO, Sabine Radmacher, COO
Telephone：+49 (0)8031 860 92-0
Email：info@rivolution.de
Orders：order@rivolution.de
www.rivolution.de
The Insides Company
Mark Harvie, Consultant
Telephone：+44 7970 546778
Email：sales@theinsides.co
.png){kind=small}
